RETRACTED: The clinical evaluation of combined detection of microcirculation, lipid metabolism, and inflammatory-related factors in the treatment of diabetic nephropathy with atorvastatin
Saved in:
| Main Authors: | Haicheng Wang, Zhengfang Zhang, Jiali Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2019-04-01
|
| Series: | European Journal of Inflammation |
| Online Access: | https://doi.org/10.1177/2058739219847830 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RETRACTED: Effects of combined use of atorvastatin and losartan in treating patients with diabetic nephropathy
by: Chao Ding, et al.
Published: (2018-10-01) -
The impact of atorvastatin on hemorheology and inflammatory cytokines of patients with hypertensive nephropathy
by: WANG Li, et al.
Published: (2017-01-01) -
Efficacy and Safety of the Fixed-Dose Combination of Atorvastatin/Fenofibrate Versus Atorvastatin on the Lipid Profile of Patients with Type 2 Diabetes and Dyslipidemia
by: Francisco G. Padilla-Padilla, et al.
Published: (2025-05-01) -
Association of diabetic nephropathy with lipid metabolism: a Mendelian randomization study
by: Pengfei Xie, et al.
Published: (2025-03-01) -
Vitamin D Levels and Lipid Response to Atorvastatin
by: José Luis Pérez-Castrillón, et al.
Published: (2010-01-01)